{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:18:44Z","timestamp":1787170724189,"version":"build-2736575974"},"reference-count":37,"publisher":"Pharmaceutical Society of Japan","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2019,12,1]]},"DOI":"10.1248\/bpb.b19-00474","type":"journal-article","created":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T06:48:12Z","timestamp":1575269292000},"page":"2002-2008","source":"Crossref","is-referenced-by-count":16,"title":["Metformin Induces Oxidative Stress-Mediated Apoptosis without the Blockade of Glycolysis in H4IIE Hepatocellular Carcinoma Cells"],"prefix":"10.1248","volume":"42","author":[{"given":"Deokbae","family":"Park","sequence":"first","affiliation":[{"name":"Department of Histology, School of Medicine, Jeju National University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) Viollet B, Guigas B, Sanz Garcia N, Leclerc J, Foretz M, Andreelli F. Cellular and molecular mechanisms of metformin: an overview. <i>Clin. Sci.<\/i> (Lond.), <b>122<\/b>, 253\u2013270 (2012)."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Stephenne X, Foretz M, Taleux N, van der Zon GC, Sokal E, Hue L, Viollet B, Guigas B. Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status. <i>Diabetologia<\/i>, <b>54<\/b>, 3101\u20133110 (2011).","DOI":"10.1007\/s00125-011-2311-5"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Gunton JE, Delhanty PJ, Takahashi S, Baxter RC. Metformin rapidly increases insulin receptor activation in human liver and signals preferentially through insulin-receptor substrate-2. <i>J. Clin. Endocrinol. Metab.<\/i>, <b>88<\/b>, 1323\u20131332 (2003).","DOI":"10.1210\/jc.2002-021394"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Quinn BJ, Kitagawa H, Memmott RM, Gills JJ, Dennis PA. Repositioning metformin for cancer prevention and treatment. <i>Trends Endocrinol. Metab.<\/i>, <b>24<\/b>, 469\u2013480 (2013).","DOI":"10.1016\/j.tem.2013.05.004"},{"key":"5","unstructured":"5) Forouzandeh F, Salazar G, Patrushev N, Xiong S, Hilenski L, Fei B, Alexander RW. Metformin beyond diabetes: pleiotropic benefits of metformin in attenuation of atherosclerosis. <i>J. Am. Heart Assoc.<\/i>, <b>3<\/b>, e001202 (2014)."},{"key":"6","unstructured":"6) Hattori Y, Hattori K, Hayashi T. Pleiotropic benefits of metformin: macrophage targeting its anti-inflammatory mechanisms. <i>Diabetes<\/i>, <b>64<\/b>, 1907\u20131909 (2015)."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Khang R, Park C, Shin JH. Dysregulation of parkin in the substantia nigra of db\/db and high-fat diet mice. <i>Neuroscience<\/i>, <b>294<\/b>, 182\u2013192 (2015).","DOI":"10.1016\/j.neuroscience.2015.03.017"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Vigneri P, Frasca F, Sciacca L, Pandini G, Vigneri R. Diabetes and cancer. <i>Endocr. Relat. Cancer<\/i>, <b>16<\/b>, 1103\u20131123 (2009).","DOI":"10.1677\/ERC-09-0087"},{"key":"9","unstructured":"9) Landman GW, Kleefstra N, van Hateren KJ, Groenier KH, Gans RO, Bilo HJ. Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16. <i>Diabetes Care<\/i>, <b>33<\/b>, 322\u2013326 (2010)."},{"key":"10","unstructured":"10) Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, Pollak M, Regensteiner JG, Yee D. Diabetes and cancer: a consensus report. <i>Diabetes Care<\/i>, <b>33<\/b>, 1674\u20131685 (2010)."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Fransgaard T, Thygesen LC, Gogenur I. Metformin increases overall survival in patients with diabetes undergoing surgery for colorectal cancer. <i>Ann. Surg. Oncol.<\/i>, <b>23<\/b>, 1569\u20131575 (2016).","DOI":"10.1245\/s10434-015-5028-8"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Otto AM. Warburg effect(s)\u2014a biographical sketch of Otto Warburg and his impacts on tumor metabolism. <i>Cancer Metab.<\/i>, <b>4<\/b>, 5 (2016).","DOI":"10.1186\/s40170-016-0145-9"},{"key":"13","unstructured":"13) Senyilmaz D, Teleman AA. Chicken or the egg: Warburg effect and mitochondrial dysfunction. <i>F1000Prime Rep.<\/i>, <b>7<\/b>, 41 (2015)."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Park DB. Metformin promotes apoptosis but suppresses autophagy in glucose-deprived H4IIE hepatocellular carcinoma cells. <i>Diabetes Metab. J.<\/i>, <b>39<\/b>, 518\u2013527 (2015).","DOI":"10.4093\/dmj.2015.39.6.518"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. <i>J. Immunol. Methods<\/i>, <b>65<\/b>, 55\u201363 (1983).","DOI":"10.1016\/0022-1759(83)90303-4"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Yin J, Hu R, Chen M, Tang J, Li F, Yang Y, Chen J. Effects of berberine on glucose metabolism <i>in vitro.<\/i> <i>Metabolism<\/i>, <b>51<\/b>, 1439\u20131443 (2002).","DOI":"10.1053\/meta.2002.34715"},{"key":"17","unstructured":"17) Halliwell B, Whiteman M. Measuring reactive species and oxidative damage <i>in vivo<\/i> and in cell culture: how should you do it and what do the results mean? <i>Br. J. Pharmacol.<\/i>, <b>142<\/b>, 231\u2013255 (2004)."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Owen MR, Doran E, Halestrap AP. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. <i>Biochem. J.<\/i>, <b>348<\/b>, 607\u2013614 (2000).","DOI":"10.1042\/bj3480607"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Andrzejewski S, Gravel SP, Pollak M, St-Pierre J. Metformin directly acts on mitochondria to alter cellular bioenergetics. <i>Cancer Metab.<\/i>, <b>2<\/b>, 12 (2014).","DOI":"10.1186\/2049-3002-2-12"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Li N, Ragheb K, Lawler G, Sturgis J, Rajwa B, Melendez JA, Robinson JP. Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. <i>J. Biol. Chem.<\/i>, <b>278<\/b>, 8516\u20138525 (2003).","DOI":"10.1074\/jbc.M210432200"},{"key":"21","unstructured":"21) Hsu PP, Sabatini DM. Cancer cell metabolism: Warburg and beyond. <i>Cell<\/i>, <b>134<\/b>, 703\u2013707 (2008)."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Griss T, Vincent EE, Egnatchik R, Chen J, Ma EH, Faubert B, Viollet B, DeBerardinis RJ, Jones RG. Metformin antagonizes cancer cell proliferation by suppressing mitochondrial-dependent biosynthesis. <i>PLOS Biol.<\/i>, <b>13<\/b>, e1002309 (2015).","DOI":"10.1371\/journal.pbio.1002309"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Loubiere C, Clavel S, Gilleron J, Harisseh R, Fauconnier J, Ben-Sahra I, Bost F. The energy disruptor metformin targets mitochondrial integrity <i>via<\/i> modification of calcium flux in cancer cells. <i>Sci. Rep.<\/i>, <b>7<\/b>, 5040 (2017).","DOI":"10.1038\/s41598-017-05052-2"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Yang H, Villani RM, Wang H, Simpson MJ, Roberts MS, Tang M, Liang X. The role of cellular reactive oxygen species in cancer chemotherapy. <i>J. Exp. Clin. Cancer Res.<\/i>, <b>37<\/b>, 266 (2018).","DOI":"10.1186\/s13046-018-0909-x"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Mogavero A, Maiorana MV, Zanutto S, Varinelli L, Bozzi F, Belfiore A, Volpi CC, Gloghini A, Pierotti MA, Gariboldi M. Metformin transiently inhibits colorectal cancer cell proliferation as a result of either AMPK activation or increased ROS production. <i>Sci. Rep.<\/i>, <b>7<\/b>, 15992 (2017).","DOI":"10.1038\/s41598-017-16149-z"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Bridges HR, Jones AJ, Pollak M, Hirst J. Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria. <i>Biochem. J.<\/i>, <b>462<\/b>, 475\u2013487 (2014).","DOI":"10.1042\/BJ20140620"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Jiang JX, T\u00f6r\u00f6k NJ. NADPH Oxidases in chronic liver diseases. <i>Adv. Hematol.<\/i>, <b>2014<\/b>, 742931 (2014).","DOI":"10.1155\/2014\/742931"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Salani B, Marini C, Rio AD, Ravera S, Massollo M, Orengo AM, Amaro A, Passalacqua M, Maffioli S, Pfeffer U, Cordera R, Maggi D, Sambuceti G. Metformin impairs glucose consumption and survival in Calu-1 cells by direct inhibition of hexokinase-II. <i>Sci. Rep.<\/i>, <b>3<\/b>, 2070 (2013).","DOI":"10.1038\/srep02070"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Fendt SM, Bell EL, Keibler MA, Davidson SM, Wirth GJ, Fiske B, Mayers JR, Schwab M, Bellinger G, Csibi A, Patnaik A, Blouin MJ, Cantley LC, Guarente L, Blenis J, Pollak MN, Olumi AF, Vander Heiden MG, Stephanopoulos G. Metformin decreases glucose oxidation and increases the dependency of prostate cancer cells on reductive glutamine metabolism. <i>Cancer Res.<\/i>, <b>73<\/b>, 4429\u20134438 (2013).","DOI":"10.1158\/0008-5472.CAN-13-0080"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Yu T, Robotham JL, Yoon Y. Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>, <b>103<\/b>, 2653\u20132658 (2006).","DOI":"10.1073\/pnas.0511154103"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Liemburg-Apers DC, Willems PH, Koopman WJ, Grefte S. Interactions between mitochondrial reactive oxygen species and cellular glucose metabolism. <i>Arch. Toxicol.<\/i>, <b>89<\/b>, 1209\u20131226 (2015).","DOI":"10.1007\/s00204-015-1520-y"},{"key":"32","unstructured":"32) Galloway CA, Yoon Y. Perspectives on: SGP symposium on mitochondrial physiology and medicine: What comes first, misshape or dysfunction? The view from metabolic excess. <i>J. Gen. Physiol.<\/i>, <b>139<\/b>, 455\u2013463 (2012)."},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Le A, Cooper CR, Gouw AM, Dinavahi R, Maitra A, Deck LM, Dang CV. Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>, <b>107<\/b>, 2037\u20132042 (2010).","DOI":"10.1073\/pnas.0914433107"},{"key":"34","unstructured":"34) Inoguchi T, Battan R, Handler E, Sportsman JR, Heath W, King GL. Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>, <b>89<\/b>, 11059\u201311063 (1992)."},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Eun HS, Cho SY, Joo JS, Kang SH, Moon HS, Lee ES, Kim SH, Lee BS. Gene expression of NOX family members and their clinical significance in hepatocellular carcinoma. <i>Sci.Rep.<\/i>, <b>7<\/b>, 11060 (2017).","DOI":"10.1038\/s41598-017-11280-3"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Fujita R, Ueda H. Protein kinase C-mediated cell death mode switch induced by high glucose. <i>Cell Death Differ.<\/i>, <b>10<\/b>, 1336\u20131347 (2003).","DOI":"10.1038\/sj.cdd.4401300"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Pacheco ME, Beltran A, Redondo J, Manso AM, Alonso MJ, Salaices M. High glucose enhances inducible nitric oxide synthase expression. Role of protein kinase C-betaII. <i>Eur. J. Pharmacol.<\/i>, <b>538<\/b>, 115\u2013123 (2006).","DOI":"10.1016\/j.ejphar.2006.03.052"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/42\/12\/42_b19-00474\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T22:25:05Z","timestamp":1575671105000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/42\/12\/42_b19-00474\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,1]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b19-00474","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,1]]}}}